Article Information
- Received December 12, 2001
- Revision received December 12, 2001
- Accepted January 14, 2002
- First published April 15, 2002.
- Version of record published April 15, 2002.
Author Information
- Steven J. Tavalin1,
- Marcie Colledge1,
- Johannes W. Hell2,
- Lorene K. Langeberg1,
- Richard L. Huganir3, and
- John D. Scott1
- 1Howard Hughes Medical Institute, Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201,
- 2Department of Pharmacology, University of Iowa, Iowa City, Iowa 52242, and
- 3Howard Hughes Medical Institute, Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
Author contributions
Disclosures
- Received December 12, 2001.
- Revision received December 12, 2001.
- Accepted January 14, 2002.
This work was supported by grants from the Medical Research Council of Canada (M.C.) and National Institutes of Health Grants NS10202 (S.J.T.), NS35563 (J.W.H), and GM48321 (J.D.S.). We thank Ann Westphal and Jackie Soderling for preparation of the hippocampal cultures and Robert Mouton for preparation of HEK293 cells for biochemical experiments. We thank Gary Westbrook for critical review of this manuscript and Craig Jahr and members of the Scott laboratory for many critical discussions.
Correspondence should be addressed to John D. Scott, Howard Hughes Medical Institute, Vollum Institute, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, Portland, Oregon 97201. E-mail:scott{at}ohsu.edu.
S. J. Tavalin's present address: Department of Pharmacology, University of Tennessee, Health Science Center, Memphis, TN 38163.
